FTC Investigates Zicam “3X Faster” Cold Resolution Claims
This article was originally published in The Tan Sheet
Executive Summary
FTC is investigating whether Matrixx Initiatives engaged in deceptive or unfair advertising practices for the firm's Zicam cold remedy line, according to the company
You may also be interested in...
Zicam Ad Claims Backed By Science, NAD Concludes
Efficacy claims in advertising for Matrixx Initiatives' Zicam cold remedy are adequately supported with clinical studies, according to NAD
Judge Orders FDA, Food Safety Group To Set FSMA Implementation Date
FDA’s delays in implementing the Food Safety Modernization Act violated FSMA and the Administrative Procedures Act, a federal court finds in an April 22 order. The agency must meet with plaintiff Center for Food Safety to agree on new implementation deadlines by May 20.
Judge Orders FDA, Food Safety Group To Set FSMA Implementation Date
FDA’s delays in implementing the Food Safety Modernization Act violated FSMA and the Administrative Procedures Act, a federal court finds in an April 22 order. The agency must meet with plaintiff Center for Food Safety to agree on new implementation deadlines by May 20.